Log In
Print
BCIQ
Print
Print this Print this
 

Ofirmev, Perfalgan, IV acetaminophen (formerly Acetavance)

Also known as: IV APAP

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionIV formulation of acetaminophen
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat acute pain and fever; Treat acute pain or fever in adults; Treat acute pain or fever in pediatric patients; Treat mild to moderate pain; Treat moderate to severe pain with adjunctive opioid analgesics; Treat pain and fever; Treat post-operative pain following abdominal gynecological surgery; Treat post-operative pain following abdominal laparoscopic surgery
Regulatory Designation

Partner

Mallinckrodt plc


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,300.0M

$1,300.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today